Suicide Clinical Trial - Youth Nominated Support Team

Status Not yet recruiting

Clinical Trial Summary

This study aims to adapt the current Youth-Nominated Support Team (YST) manual used to treat suicide risk for people at clinical high risk for psychosis.

Clinical Trial Description

Psychotic disorders are characterized by high rates of suicidal ideation and behavior, and the risk for suicide appears to be greatest during the earliest stages of psychosis. A recent meta-analysis showed that the majority of youth at clinical high-risk (CHR) for psychosis experience suicidal ideation, and that approximately one in five make at least one suicide attempt. There are, however, no suicide prevention interventions specifically tailored to the needs of transition-aged youth at CHR, and no current best practice guidelines for how to respond to suicide risk in this population. The Youth-Nominated Support Team (YST) intervention has recently been shown to reduce mortality among adolescents and is potentially highly adaptable within the context of existing CHR services. YST is intended as an adjunctive treatment and is primarily delivered towards support persons rather than the youth themselves, and therefore would not interfere or overlap with the already extensive direct services provided in CHR treatment settings. The proposed project intends to adapt the YST intervention for CHR populations. Specifically, the investigators aim to: (1) adapt YST for CHR based on stakeholder input (i.e., clients, family/friends, clinicians) and to develop a new treatment manual and submit an additional IRB to cover the next two aims -- (2) to implement YST in a single CHR clinic and to revise the intervention based on input from clients, providers, and support person and (3) conduct a pilot randomized clinical trial at four SAMHSA funded CHR sites to test the efficacy of the adapted YST intervention and to identify underlying mechanisms of change. The investigators hypothesize that the revised intervention will be superior to existing practice for the reduction of suicidal ideation and behavior. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05558332
Study type	Interventional
Source	University of California, Irvine
Contact	Jason E Schiffman, PhD
Phone	424-291-2159
Email	jeschiff@uci.edu
Status	Not yet recruiting
Phase	N/A
Start date	September 2024
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04127292` - Impact of Clinician Virtual Human Interaction Training in Emotional Self-Awareness on Patients Suicidal Ideation and Suicide Crisis Syndrome	N/A
Recruiting	`NCT06079853` - Nurse Suicide: Physiologic Sleep Health Promotion Trial	N/A
Recruiting	`NCT05423483` - Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents	Phase 2
Completed	`NCT03272048` - Identifying Effective Approaches to Counseling on Firearm Safety	N/A
Completed	`NCT05514587` - Meaning of Life Questionnaire (MLQ) in Patients Admitted to the Crisis Centre (MSVCAC)
Enrolling by invitation	`NCT05639426` - Preventing Youth Violence Through Building Equitable Communities	N/A
Completed	`NCT03703128` - Suicide in People Aged 45-60: A Case-control Psychological Autopsy Study
Completed	`NCT03646903` - Reducing Help-Seeking Stigma in Young Adults at Elevated Suicide Risk	N/A
Not yet recruiting	`NCT06349915` - A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents	N/A
Completed	`NCT02718248` - Ottawa Suicide Prevention in Men Pilot Study	N/A
Completed	`NCT02094898` - Ketamine for Depression and Suicide Risk	Phase 2
Completed	`NCT01594138` - Linguistic Characteristics of Suicidal Patients in the Emergency Department	N/A
Completed	`NCT01360736` - A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL)	N/A
Completed	`NCT02228044` - Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment	N/A
Completed	`NCT00604097` - Preventing Youth Suicide in Primary Care: A Family Model	Phase 3
Completed	`NCT00387855` - An Evaluation of the SOS (Suicide Prevention) Program	N/A
Recruiting	`NCT03519802` - Evaluation of Cognitive Function in a Suicidal Crisis
Completed	`NCT05580757` - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Recruiting	`NCT03030924` - Wearable Suicidal Early Warning System for Adolescents
Completed	`NCT03280225` - REACH VET Implementation Program Evaluation

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Youth Nominated Support Team — YST

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms